These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 2061978)

  • 21. Final report on the aspirin component of the ongoing Physicians' Health Study.
    Steering Committee of the Physicians' Health Study Research Group
    N Engl J Med; 1989 Jul; 321(3):129-35. PubMed ID: 2664509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians.
    O'Donnell CJ; Ridker PM; Glynn RJ; Berger K; Ajani U; Manson JE; Hennekens CH
    Circulation; 1997 Mar; 95(5):1132-7. PubMed ID: 9054841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
    Bartolucci AA; Howard G
    Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women.
    Manson JE; Hu FB; Rich-Edwards JW; Colditz GA; Stampfer MJ; Willett WC; Speizer FE; Hennekens CH
    N Engl J Med; 1999 Aug; 341(9):650-8. PubMed ID: 10460816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.
    Ridker PM; Manson JE; Gaziano JM; Buring JE; Hennekens CH
    Ann Intern Med; 1991 May; 114(10):835-9. PubMed ID: 2014943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood socioeconomic status and risk of cardiovascular disease in middle aged US women: a prospective study.
    Gliksman MD; Kawachi I; Hunter D; Colditz GA; Manson JE; Stampfer MJ; Speizer FE; Willett WC; Hennekens CH
    J Epidemiol Community Health; 1995 Feb; 49(1):10-5. PubMed ID: 7706992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups.
    Gelbenegger G; Postula M; Pecen L; Halvorsen S; Lesiak M; Schoergenhofer C; Jilma B; Hengstenberg C; Siller-Matula JM
    BMC Med; 2019 Nov; 17(1):198. PubMed ID: 31679516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.
    Dagenais GR; Yi Q; Lonn E; Sleight P; Ostergren J; Yusuf S;
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):75-81. PubMed ID: 15703510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
    Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
    JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin in the treatment and prevention of cardiovascular disease.
    Gaziano JM; Skerrett PJ; Buring JE
    Haemostasis; 2000; 30 Suppl 3():1-13. PubMed ID: 11182624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study.
    Vittinghoff E; Shlipak MG; Varosy PD; Furberg CD; Ireland CC; Khan SS; Blumenthal R; Barrett-Connor E; Hulley S;
    Ann Intern Med; 2003 Jan; 138(2):81-9. PubMed ID: 12529088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial.
    Blomster JI; Woodward M; Zoungas S; Hillis GS; Harrap S; Neal B; Poulter N; Mancia G; Chalmers J; Huxley R
    BMJ Open; 2016 Jan; 6(1):e009668. PubMed ID: 26747037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bariatric surgery and long-term cardiovascular events.
    Sjöström L; Peltonen M; Jacobson P; Sjöström CD; Karason K; Wedel H; Ahlin S; Anveden Å; Bengtsson C; Bergmark G; Bouchard C; Carlsson B; Dahlgren S; Karlsson J; Lindroos AK; Lönroth H; Narbro K; Näslund I; Olbers T; Svensson PA; Carlsson LM
    JAMA; 2012 Jan; 307(1):56-65. PubMed ID: 22215166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasectomy and subsequent cardiovascular disease in US physicians.
    Manson JE; Ridker PM; Spelsberg A; Ajani U; Lotufo PA; Hennekens CH
    Contraception; 1999 Mar; 59(3):181-6. PubMed ID: 10382081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease.
    Hebert PR; Hennekens CH
    Arch Intern Med; 2000 Nov; 160(20):3123-7. PubMed ID: 11074741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care.
    Rodríguez LA; Cea-Soriano L; Martín-Merino E; Johansson S
    BMJ; 2011 Jul; 343():d4094. PubMed ID: 21771831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force.
    Guirguis-Blake JM; Evans CV; Senger CA; O'Connor EA; Whitlock EP
    Ann Intern Med; 2016 Jun; 164(12):804-13. PubMed ID: 27064410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-selected posttrial aspirin use and subsequent cardiovascular disease and mortality in the physicians' health study.
    Cook NR; Hebert PR; Manson JE; Buring JE; Hennekens CH
    Arch Intern Med; 2000 Apr; 160(7):921-8. PubMed ID: 10761956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.
    Solomon DH; Karlson EW; Rimm EB; Cannuscio CC; Mandl LA; Manson JE; Stampfer MJ; Curhan GC
    Circulation; 2003 Mar; 107(9):1303-7. PubMed ID: 12628952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.